期刊文献+

两种细胞因子联合应用对骨髓基质干细胞增殖和成骨活性的影响

Effects of fusion bone morphogenetic proteins and basic fibroblast growth factors on proliferation and osteogenic activity of rabbit bone mesenchymal stem cells (BMSCs) in vitro
原文传递
导出
摘要 目的 研究骨形态发生蛋白融合基因-4/7(BMP-4/7)和碱性成纤维细胞生长因子(bFGF)联合应用对体外培养兔骨髓基质干细胞(BMSCs)增殖和成骨活性的影响.方法 体外培养BMSCs,在第3代细胞培养液中加入不同浓度的BMP-4/7和bFGF,依据加入不同基因浓度组合的不同分为5个实验组(A组:80 ng/mL BMP-4/7,B组:80 ng/mL bFGF,C组:30 ng/mL BMP-4/7+30ng/mL bFGF,D组:50 ng/mL BMP-4/7+50 ng/mL bFGF,E组:80 ng/mL BMP-4/7+80 ng/mL bFGF)和对照组(不加任何因子),采用绘制生长曲线,甲基噻唑基四唑(MTT)比色法检测细胞增殖活力,碱性磷酸酶(ALP)和降钙素(OC)活性检测法比较各组间差异,观察不同浓度的BMP-4/7和bFGF联合应用对兔BMSCs增殖和成骨活性的影响. 结果 传代后第5天对照组个别单核细胞贴壁,呈长梭形 A组细胞增殖,呈旋涡状排列 B组细胞较为密集,部分融合成片 C组细胞呈集落式生长,生长旺盛 D组细胞生长密集,可见明显的钙结节 E组细胞密集,可见细胞性钙结节形成.各组OD值、ALP含量、OC含量随着作用时间的延长而增加,各组不同培养时间的OD值差异均有统计学意义(P〈0.01) 且C、D、E组均高于A、B组,差异均有统计学意义(P〈0.05).C、D、E组内随着作用浓度的增加,细胞增殖及成骨活性增强,呈浓度依赖关系,差异均有统计学意义(P〈0.05). 结论 合理的联合应用BMP-4/7和bFGF可促进BMSCs细胞增殖,促进成骨活性,两者对BMSCs有明显的协同增强效应. Objective To study the combined effects of basic fibroblast growth factor (bFGF) and fusion bone morpbogenetic gene protein-4/7 (BMP-4/7) on proliferation and osteogenic activity of rabbit bone mesenchymal stem cells (BMSCs) in vitro. Methods BMSCs cells were cultured in vitro. Different concentrations of BMP-4/7 and bFGF were added into the culture of the third passage. Five experimental groups were established according to the concentration of BMP-4/7 and bFGF. Group A: 80 ng/mL BMP-4/7 group B: 80 ng/mL bFGF group C: 30 ng/mL BMP-4/7 +30 ng/mL bFGF group D: 50 ng/mL BMP-4/7 +50 ng/mL bFGF group E: 80 ng/mL BMP-4/7 +80 ng/mL bFGF) . No growth factor was added into the culture fluid in the control. The growth curve drawing, methyl thiazolyl tetrazolium (MTT), alkaline pbosphatase (ALP) and osteocalcin (OC) dynamics were used to compare the differences between the groups and observe the effects of BMP-4/7 plus bFGF on proliferation and osteogenic differentiation of BMSCs. Results Compared with the control group, single BMP-4/7 had promotive effects on the pro-liferation and osteogenic differentiation of BMSCs, while single bFGF contributed to the proliferation of BMSCs significandy hut inhibited the osteogenic differentiation of BMSCs. The combination of BMP-4/7 and bFGF promoted not only the BMSCs proliferation significantly but also the osteogenic differentiation of BMSCs,showing positive correlation with action time and concentration. Conclusion A rational combined use of BMP-4/7 and bFGF can promote the proliferation and osteogenic differentiation of BMSCs and the two factors have significant synergistic effect on BMSCs.
出处 《中华创伤骨科杂志》 CAS CSCD 2010年第3期247-251,共5页 Chinese Journal of Orthopaedic Trauma
基金 黑龙江省自然科学基金资助(D200876) 黑龙江省教育厅科学技术研究项目资助(11531149)
关键词 骨形态发生蛋白质类 骨髓细胞 成纤维细胞生长因子 细胞增殖 Bone morphogenetic proteins Bone marrow cells Fibroblast growth factor Cell proliferation
  • 相关文献

参考文献13

  • 1Simons M.Integrative signaling in angiogenesis.Mol Cell Biochem,2004,264:99-102.
  • 2袁绍辉,尚剑,邵国军,毕郑钢.融合基因骨形态发生蛋白-4/7重组腺相关病毒载体转染对骨髓基质干细胞成骨活性的作用[J].中华创伤骨科杂志,2008,10(11):1053-1057. 被引量:3
  • 3Bhindi R,Brieger D,Ishii H,et al.Fibrublast growth factor 2 and the transcription factor Egr-1 localise to endothelial cell microvascular channels in human coronary artery occlusion,Thromb Haemost,2005,93:172-174.
  • 4Kumar S,Mahendra G,Nagy TR,et al.Osteogenic differentiation of recombinant adeno-associated virus 2-transduced marine mesenchymal stem cells and development of an immunocompetent mouse model for ex vivo osteoporosis gene therapy.Hum Gene Ther,2004,15:1197-1206.
  • 5Zhu L,Liu W,Cui L,et al.Tissue-engineered bone repair of goat-femur defects with osteogenically induced bone marrow stromal cells.Tissue Eng,2006,12:423-433.
  • 6Gregory CA,Prockop DJ,Spees JL,Non-hematopoietic bone marrow stem cells:molecular control of expansion and differentiation.Exp Cell Res,2005,306:330-335.
  • 7Ai-Aql ZS,Alagl AS,Graves DT,et al.Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis.J Dent Res,2008,87:107-118.
  • 8Liebermann J,Tucker MJ.Vitrifying and warming of human oocytes,embryos,and blastocysts:verifications procedures as an alternative to conventional cryopreservation.Methods Mol Biol,2004,254:345-364.
  • 9Chancellor MB,Kianifard F,Beamer E,et al.A comparison of the efficacy of darifenacin alone vs.darifenacin plus a Behavioural Modification Programme upon the symptoms of overactive bladder.Int J Clin Pract,2008,62:606-613.
  • 10Dumont F,Marechal PA,Gervais P.Cell size and water permeability as determining factors for cell viability after freezing at different cooling rates.Appl Environ Microbiol,2004,70:268-272.

二级参考文献25

  • 1阮瑰.血管生长及其调控[J].微循环学杂志,1996,6(2):35-37. 被引量:1
  • 2Oreffo RO, Triffitt JT. Future potentials for using osteogenic stem cells and biomaterials in orthopedics. Bone, 1999, 25(2 Suppl): 5-9.
  • 3Sanjay K, Gandham M, Timr N, et al. Osteogenic differentiation of recombinant adeno-associated virus 2-transduced murine mesenchymal stem ceils and development of an immunocompetent mouse model for es vivo osteoporosis gene therapy. Hum Gene Ther, 2004, 15: 1197-1206.
  • 4Zhu L, Liu W, Cui L, et al. Tissue-engineered bone repair of goat-femur defects with osteogenically induced bone marrow stromal ceils. Tissue Eng, 2006, 12: 423-433.
  • 5Gregory CA, Prockop DJ, Specs JL. Non-hematopoietic bone marrow stem ceils: molecular control of expansion and differentiation. Exp Cell Res, 2005, 306: 330-335.
  • 6Flotte TR Gene therapy progress and prospects: recombinant adeno-associatedvirus (rAAV) vectors, Gene Ther, 2004, 11:805-810.
  • 7Chao H, Christopher CE. AAV vectors for hemophilia B gene therapy. Mt Sinai J Med, 2004, 71: 305-313.
  • 8McCarty DM, Young SM Jr, Samulski RJ. Integration of adeno-associated virus (AAV) and recombinant AAV vectors. Annu Rev Genet, 2004, 38: 819-845.
  • 9Shiau AL, Liu PS, Wu CL Novel strategy for generation and titration of recombinant adeno-associated virus vectors. J Virol, 2005, 79: 193-201.
  • 10Flotte TR, Zeitlin PL, Reynolds TC, et al. Phase I trial of intranasal and endobronehial administration of a recombinant adeno-assoeiated virus serotype 2 (rAAV2) CFFR vector in adult cystic fibrosis patients: a two-part clinical study. Hum Gene Ther, 2003, 14:1079-1088.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部